Capsules used in dry powder inhalers (DPI) are, in many ways, different from those that are orally administered. From a regulatory perspective, capsules for inhalation must comply with the compendialrequirements for inhalation products, highlights Fr d rique Bordes-Picard, manager, PharmaceutiOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.